Executive Summary
Azoth Analytics has released a research report titled "North America Cannabis Market (2023 Edition)" which provides a complete analysis of the North American Cannabis industry in terms of market segmentation By Derivative (CBD, THC, and Other Derivatives), By Source (Marijuana, and Hemp), By End Use (Medical, Recreational, and Therapeutic) for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.
The North America Cannabis market showcased growth at a CAGR of 10.20% during 2019-2022. The market was valued at USD 25.82 Billion in 2022 which is expected to reach USD 54.52 Billion in 2029. The cultivation of cannabis has become more sophisticated, with the advent of modern growing techniques and technologies. This has led to increased product quality and diversity, ranging from traditional flower products to concentrates, edibles, topicals, and more.
The North America Cannabis Market is expected to grow at a CAGR of 11.49% during the forecast period. E-commerce platforms and online delivery services have gained popularity, allowing consumers to conveniently purchase cannabis products. However, regulations and restrictions vary across different jurisdictions, impacting the availability and accessibility of these services. Moreover, the industry consists of various sectors, including cultivation, manufacturing, distribution, and retail. Licensed producers and dispensaries play a vital role in supplying cannabis products to consumers, both for medical and recreational purposes.
Additionally, research and development in the cannabis industry have been ongoing, focusing on refining cultivation techniques, exploring new medical applications, and developing alternative consumption methods. This continuous advancement contributes to the expansion and maturation of the North American cannabis market.
The implementation of innovative and diversified product offers serves to accommodate a wider range of consumers. The expansion and diversification of the cannabis market's client base can be achieved by the development of goods that cater to a wide range of demographics, encompassing both novice users and experienced consumers. The advent of innovative products has provided consumers with the opportunity to personalize and tailor their cannabis experience according to their preferences. The act of personalizing cannabis experiences, whether it be through the selection of certain strains, adjusting dose levels, or choosing different consuming methods, has been found to significantly boost user happiness and promote customer loyalty.
The development of high-quality concentrates, such as shatter, wax, and live resin, caters to experienced users seeking potent and flavorful options. Concentrates offer a premium experience for enthusiasts.
The decrease in the stigmatization of cannabis usage can be attributed to the increased level of social acceptance. Consequently, an increasing number of persons are receptive to regarding cannabis as a real and valid option for both medical and recreational applications. The cannabis customer base has experienced growth as a result of a society that is increasingly receptive. Individuals from various age cohorts, socio-cultural origins, and demographic profiles exhibit an increased inclination towards the exploration of cannabis-based products.
The increasing cultural acceptability of cannabis has had a significant impact on legislative reforms. As societal attitudes increasingly favor pro-cannabis legislation, governments have demonstrated a growing inclination towards the legalization and regulation of the cannabis business. Social acceptance has encouraged efforts to educate the public about cannabis. This includes information about responsible use, health effects, and the potential benefits of cannabis.
Scope of the Report
• The report analyses the Cannabis Market by Value (USD Billion).
• The report presents the country-wise number of users of Cannabis for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029 in North America.
• The report presents the analysis of the Cannabis Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the Cannabis Market By derivatives (CBD, THC, and Other Derivatives).
• The report analyses the Cannabis Market By Source (Marijuana, and Hemp).
• The report analyses the Cannabis Market By End Use (Medical, Recreational, and Therapeutic).
• The report presents the country-wise penetration rate of Cannabis for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029 in North America.
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Types, by mode of operation & by end users.
• Also, the major opportunities, trends, drivers and challenges of the industry have been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include oCanopy Growth Corporation, Gw Pharmaceuticals Limited, Aurora cannabis inc., Coronos Group, Tilray, Sundial Growers, Medipharm Labs Corp., Curaleaf, Pure sunfarms corp., and Trulieve Cannabis Corp.
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
3. Global Cannabis Market: Historic and Forecast
3.1 Global Cannabis Market: Market Value Assessment
4. North America Cannabis Market: Historic and Forecast (2019-2029)
4.1 Impact Analysis of Macro Economic Factors on the North American Cannabis Market
4.2 North America Cannabis Market: Ecosystem Analysis
4.2.1 Projected Growth in Global Medical Cannabis Patients Population (Millions)
4.2.2 Cannabis Market Consumer Spending Statistics
4.3 North America Cannabis Market: Dashboard
4.4 North America Cannabis Market: Market Value Assessment
4.5 North America Cannabis Market: User Statistics
4.6 End-use wise Penetration of Cannabis in North America
4.7 Impact of COVID-19 on North American Cannabis Market
4.8 North America Cannabis Market Segmentation: By Derivative
4.8.1 North America Cannabis Market: By Derivative Overview
4.8.2 North America Cannabis Market: By Derivative
4.8.3 North America Cannabis Market Size, By CBD, By Value, 2019H-2029F (USD Million & CAGR)
4.8.4 North America Cannabis Market Size, By THC, By Value, 2019H-2029F (USD Million & CAGR)
4.8.5 North America Cannabis Market Size, By Other Derivatives, By Value, 2019H-2029F (USD Million & CAGR)
4.9 North America Cannabis Market Segmentation: By End Use
4.9.1 North America Cannabis Market: By End Use Overview
4.9.2 North America Cannabis Market: By End Use
4.9.3 North America Cannabis Market Size, By Medical, By Value, 2019H-2029F (USD Million & CAGR)
4.9.4 North America Cannabis Market Size, By Recreational, By Value, 2019H-2029F (USD Million & CAGR)
4.9.5 North America Cannabis Market Size, By Therapeutic, By Value, 2019H-2029F (USD Million & CAGR)
4.10 North America Cannabis Market Segmentation: By Source
4.10.1 North America Cannabis Market: By Source Overview
4.10.2 North America Cannabis Market: By Source
4.10.3 North America Cannabis Market Size, By Marijuana, By Value, 2019H-2029F (USD Million & CAGR)
4.10.4 North America Cannabis Market Size, By Hemp, By Value, 2019H-2029F (USD Million & CAGR)
5. North America Cannabis Market: Country Analysis
5.1 Country Snapshot
5.2 North America Cannabis Market: By Country Overview
6. United States Cannabis Market: Market Value Assessment, 2019H-2029F (USD Million & CAGR)
6.1 United States Cannabis Market: Market Value Assessment
6.2 United States Cannabis Market: User Statistics
6.3 End-use wise Penetration of Cannabis in United States
6.4 United States Cannabis Market: Market Value Assessment
6.5 United States Cannabis Market, By Derivative Overview
6.6 United States Cannabis Market Segmentation: By Derivative
6.6.1 United States Cannabis Market Size, By CBD, By Value, 2019H-2029F (USD Million & CAGR)
6.6.2 United States Cannabis Market Size, By THC, By Value, 2019H-2029F (USD Million & CAGR)
6.6.3 United States Cannabis Market Size, By Other Derivatives, By Value, 2019H-2029F (USD Million & CAGR)
6.7 United States Cannabis Market Segmentation: By End Use
6.7.1 United States Cannabis Market, By End Use Overview
6.7.2 United States Cannabis Market: By End Use
6.7.3 United States Cannabis Market Size, By Medical, By Value, 2019H-2029F (USD Million & CAGR)
6.7.4 United States Cannabis Market Size, By Recreational, By Value, 2019H-2029F (USD Million & CAGR)
6.7.5 United States Cannabis Market Size, By Therapeutic, By Value, 2019H-2029F (USD Million & CAGR)
6.8 United States Cannabis Market Segmentation: By Source
6.8.1 United States Cannabis Market, By Source Overview
6.8.2 United States Cannabis Market: By Source
6.8.3 United States Cannabis Market Size, By Marijuana, By Value, 2019H-2029F (USD Million & CAGR)
6.8.4 United States Cannabis Market Size, By Hemp, By Value, 2019H-2029F (USD Million & CAGR)
7. Canada Cannabis Market: Market Value Assessment, 2019H-2029F (USD Million & CAGR)
7.1 Canada Cannabis Volume Assessment
7.2 Canada Cannabis Market: User Statistics
7.3 End-use Penetration of Cannabis in Canada
7.4 Canada Cannabis Market: Market Value Assessment
7.5 Canada Cannabis Market, By Derivative Overview
7.6 Canada Cannabis Market Segmentation: By Derivative
7.6.1 Canada Cannabis Market Size, By CBD, By Value, 2019H-2029F (USD Million & CAGR)
7.6.2 Canada Cannabis Market Size, By THC, By Value, 2019H-2029F (USD Million & CAGR)
7.6.3 Canada Cannabis Market Size, By Other Derivatives, By Value, 2019H-2029F (USD Million & CAGR)
7.7 Canada Cannabis Market Segmentation: By End Use
7.7.1 Canada Cannabis Market, By End Use Overview
7.7.2 Canada Cannabis Market: By End Use
7.7.3 Canada Cannabis Market Size, By Medical, By Value, 2019H-2029F (USD Million & CAGR)
7.7.4 Canada Cannabis Market Size, By Recreational, By Value, 2019H-2029F (USD Million & CAGR)
7.7.5 Canada Cannabis Market Size, By Therapeutic, By Value, 2019H-2029F (USD Million & CAGR)
7.8 Canada Cannabis Market Segmentation: By Source
7.8.1 Canada Cannabis Market, By Source Overview
7.8.2 Canada Cannabis Market: By Source
7.8.3 Canada Cannabis Market Size, By Marijuana, By Value, 2019H-2029F (USD Million & CAGR)
7.8.4 Canada Cannabis Market Size, By Hemp, By Value, 2019H-2029F (USD Million & CAGR)
8. Mexico Cannabis Market: Market Value Assessment, 2019H-2029F (USD Million & CAGR)
8.1 Mexico Cannabis Volume Assessment
8.2 Mexico Cannabis Market: User Statistics
8.3 End-use wise Penetration of Cannabis in Mexico
8.4 Mexico Cannabis Market: Market Value Assessment
8.5 Mexico Cannabis Market, By Derivative Overview
8.6 Mexico Cannabis Market Segmentation: By Derivative
8.6.1 Mexico Cannabis Market Size, By CBD, By Value, 2019H-2029F (USD Million & CAGR)
8.6.2 Mexico Cannabis Market Size, By THC, By Value, 2019H-2029F (USD Million & CAGR)
8.6.3 Mexico Cannabis Market Size, By Other Derivatives, By Value, 2019H-2029F (USD Million & CAGR)
8.7 Mexico Cannabis Market Segmentation: By End Use
8.7.1 Mexico Cannabis Market, By End Use Overview
8.7.2 Mexico Cannabis Market: By End Use
8.7.3 Mexico Cannabis Market Size, By Medical, By Value, 2019H-2029F (USD Million & CAGR)
8.7.4 Mexico Cannabis Market Size, By Recreational, By Value, 2019H-2029F (USD Million & CAGR)
8.7.5 Mexico Cannabis Market Size, By Therapeutic, By Value, 2019H-2029F (USD Million & CAGR)
8.8 Mexico Cannabis Market Segmentation: By Source
8.8.1 Mexico Cannabis Market, By Source Overview
8.8.2 Mexico Cannabis Market: By Source
8.8.3 Mexico Cannabis Market Size, By Marijuana, By Value, 2019H-2029F (USD Million & CAGR)
8.8.4 Mexico Cannabis Market Size, By Hemp, By Value, 2019H-2029F (USD Million & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on the North American Cannabis Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of the North America Cannabis Market
11.4 Company Profiles
11.4.1 Canopy Growth
11.4.2 GW Pharmaceuticals
11.4.3 Aurora Cannabis
11.4.4 Cronos Group
11.4.5 Tilray
11.4.6 Sundial Growers
11.4.7 MediPharm Labs
11.4.8 Curaleaf
11.4.9 Pure Sunfarm
11.4.10 Trulieve Cannabis Corporation
North America cutting tools market is projected to grow by 4.2% annually in the forecast period and reach $12.24 million by 2033. The growth is driven by the increasing production and manufacturing activities, improved operational efficiency and innovative design, and an increasing demand for power ...
North America paper machine clothing (PMC) market is projected to grow by 3.2% annually in the forecast period and reach $1.22 billion by 2033. The growth is driven by the increasing demand for paper and paper-based products across various industries, technological advancements in the papermaking pr...
North America endoscopy devices market is projected to grow by 5.6% annually in the forecast period and reach $26.25 million by 2033. The growth is driven by the increasing prevalence of chronic diseases, the growing demand for less invasive procedures, a rising adoption of disposable endoscopic com...
North America digital health and wellness market is projected to grow by 18.6% annually in the forecast period and reach $658.3 billion by 2033. The growth is driven by an increasing number of chronic diseases, the growing investment in health and wellness programs, the increased use of smartphones ...
North America connected healthcare device market is projected to grow by 18.9% annually in the forecast period and reach $106.9 billion by 2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetrati...
North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...
North America biopharmaceuticals market is projected to grow by 8.4% annually in the forecast period and reach $407.2 billion by 2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, ...
North America encoder market is projected to grow by 8.5% annually in the forecast period and reach $1.48 billion by 2033. The growth is driven by the increased need for high-level automation across various industries, the surging demand for automobile and consumer electronics, and technological adv...
North America specialty coffee market is projected to grow by 11.0% annually in the forecast period and reach $43.56 billion by 2033. The growth is driven by rising disposable income and urbanization, growing demand for on-the-go coffee, strengthening premium coffee shops, and rising preferences for...
North America drone payload market is projected to grow by 11.7% annually in the forecast period and reach $11.71 billion by 2033. The growth is driven by increasing applications of drones, rising defense investments in unmanned technologies, the development of advanced drone payload systems, increa...